Basilea's Ceftobiprole On TARGET, Needs Positive Second Study For US

Staphylococcus aureus
Staphylococcus aureus, a target for ceftobiprole • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D